BLUE MEANIE MUSHROOM: This Is What Professionals Do

Bymungus

Two trials examined the effects of active hexose correlated compound (AHCC) in people with HCC. AHCC is a prepared extract from shiitake mushroom that contain a mixture of polysaccharides including α-glucans. Matsui et al.32 enrolled 269 patients underwent HCC surgery. After surgery, 113 patients received AHCC at a dose of 3000 mg daily until the last day of follow-up or until death. The remaining 156 patients were simply recruited after surgery based on standard of care.

And did not receive AHCC

The follow-up period ranged from 2 to 117 months, and the median follow-up period was 28 months of AHCC-receiving studies, and 30 months of control group studies.

At the end of the follow-up period, 34.5% of subjects in the AHCC group had HCC recurrence, blue meanie mushroom with 66.1% in the control group (P = 0.0335). Moreover, by the end of the follow-up period, 20.4% of patients in the AHCC group had died, compared with 46.8% in the control group (P = 0.0032). Three subjects in the AHCC group chose to withdraw from the study due to mild nausea.

  • The AHCC was
  • Well tolerated
  • With no significant
  • Side effects

A recent 2019 study conducted in Japan found that the use of mushrooms as part of a diet appears to offer some prostate health benefits. This combined analysis included 36,499 men aged 40-79 followed by 13.2 years. Subjects reported the use of mushrooms as part of a diet using a regular diet questionnaire, divided into <1 time per week, 1-2 times a week, or ≥3 times a week.

The authors did not record specific types of edible mushrooms, but note that shiitake mushrooms, maitake, oyster, and white buttons are often eaten in the study area. A total of 1204 cases of prostate cancer occurred (3.3% incidence) during the 574,397 human follow-up years.

Participants who reported

High levels of mushroom use had a lower risk of prostate cancer compared to those who ate mushrooms <1 time per week. People who had mushrooms 1-2 times a week had an 8% lower risk of developing prostate cancer, and those who ate izikhathi3 times a week had a 17% lower risk, compared with men who had mushrooms once a week or less (1-2) times a week : risk levels [HRs] [95% CIs] = 0.92 [0.81–1.05]; ≥3 times per week:

HRs [95% CIs] = 0.83 [0.70–0.98]; P-trend = 02). This effect was most https://mungus.com in men 50 years of age or older. The authors note that the limitation of this study was that information about certain types of edible mushrooms was not collected, making it difficult to determine which particular mushrooms or mushrooms might be contributing to their discovery.

Mushrooms may also

Provide benefits to men who have already been diagnosed with prostate cancer. Twardowski et al.36 conducted a phase I (N = 36) study of white button mushroom powder in men with prostate cancer as evidenced by an increase in prostate specific antigen (PSA) levels. Participants had adenocarcinoma of the prostate with no evidence of metastatic disease.

In men who underwent surgery as a primary treatment, an increase in PSA ≥0.2 ng / mL increased above nadir was required to participate, as well as those with whom radiation or other local therapies were used as primary treatment, an blue meanie mushroom in PSA. of 2.0 ng / mL over nadir after treatment was required. Patients had to complete androgen deprivation treatment or chemotherapy for at least six months before enrollment.